Search Results - "Varey, Alexander H. R."

Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck by Yung, Amanda E., Crouch, Gareth, Varey, Alexander H. R., Lo, Serigne, Elliott, Michael S., Lee, Jenny, Rawson, Robert, Gupta, Ruta, Hong, Angela M., Clark, Jonathan R., Ch’ng, Sydney

“…Background pT3/4 head and neck cutaneous squamous cell carcinomas (HNcSCCs) are associated with poor outcomes, including local recurrence, metastasis and…”
Get full text

Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas by Winder, Alec A., Boyer, Zoe, Ch’ng, Sydney, Stretch, Jonathan R., Saw, Robyn P. M., Shannon, Kerwin F., Pennington, Thomas E., Nieweg, Omgo E., Varey, Alexander H. R., Scolyer, Richard A., Thompson, John F., Cust, Anne E., Lo, Serigne N., Spillane, Andrew J., Smith, Andrea L.

“…Background Predicting which patients with American Joint Committee on Cancer (AJCC) T1–T2 melanomas will have a positive sentinel lymph node (SLN) is…”
Get full text

ASO Visual Abstract: Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 Melanomas by Winder, Alec A., Boyer, Zoe, Ch’ng, Sydney, Stretch, Jonathan R., Saw, Robyn P. M., Shannon, Kerwin F., Pennington, Thomas E., Nieweg, Omgo E., Varey, Alexander H. R., Scolyer, Richard A., Thompson, John F., Cust, Anne E., Lo, Serigne N., Spillane, Andrew J., Smith, Andrea L.

Get full text

Poor Adherence to National Clinical Management Guidelines: A Population-Based, Cross-Sectional Study of the Surgical Management of Melanoma in New South Wales, Australia by Varey, Alexander H. R., Madronio, Christine M., Cust, Anne E., Goumas, Chris, Mann, Graham J., Armstrong, Bruce K., Scolyer, Richard A., Curtin, Austin M., Thompson, John F.

“…Background Standardization of the clinical management of melanoma through the formulation of national guidelines, based on interpretation of the existing…”
Get full text

ASO Visual Abstract: Benchmarking Survival Outcomes Following Surgical Management of pT3 and pT4 Cutaneous Squamous Cell Carcinoma of the Head and Neck by Yung, Amanda E., Crouch, Gareth, Varey, Alexander H. R., Lo, Serigne, Elliott, Michael S., Lee, Jenny, Rawson, Robert, Gupta, Ruta, Hong, Angela M., Clark, Jonathan R., Ch’ng, Sydney

Get full text

Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging by Gjorup, Caroline A., Woodford, Rachel, Li, Isabel, Carlino, Matteo S., Ch’ng, Sydney, Chung, David, Hsiao, Edward, Lo, Serigne N., London, Kevin, Long, Georgina V., Menzies, Alexander M., Nieweg, Omgo E., Pennington, Thomas E., Rtshiladze, Michael A., Saw, Robyn P. M., Scolyer, Richard A., Shannon, Kerwin F., Spillane, Andrew J., Stretch, Jonathan R., Thompson, John F., Varey, Alexander H. R., van Akkooi, Alexander C. J.

“…Purpose In sentinel node-positive (SN+ve) melanoma patients, active surveillance with regular ultrasound examination of the node field has become standard,…”
Get full text

ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging by Gjorup, Caroline A., Woodford, Rachel, Li, Isabel, Carlino, Matteo S., Ch’ng, Sydney, Chung, David, Hsiao, Edward, Lo, Serigne N., London, Kevin, Long, Georgina V., Menzies, Alexander M., Nieweg, Omgo E., Pennington, Thomas E., Rtshiladze, Michael A., Saw, Robyn P. M., Scolyer, Richard A., Shannon, Kerwin F., Spillane, Andrew J., Stretch, Jonathan R., Thompson, John F., Varey, Alexander H. R., van Akkooi, Alexander C. J.

Get full text

Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies by Ch'ng, Sydney, Uyulmaz, Semra, Carlino, Matteo S., Pennington, Thomas E., Shannon, Kerwin F., Rtshiladze, Michael, Stretch, Jonathan R., Nieweg, Omgo E., Varey, Alexander H.R., Hsiao, Edward, Kapoor, Rony, Pires da Silva, Ines, Lo, Serigne N., Spillane, Andrew J., Scolyer, Richard A., Long, Georgina V., Hong, Angela M., Saw, Robyn P.M., Thompson, John F., Menzies, Alexander M.

“…Although previously the mainstay of treatment, the role of surgery in the management of patients with oligometastatic stage IV melanoma has changed with the…”
Get full text

Alternative splicing of TIA-1 in human colon cancer regulates VEGF isoform expression, angiogenesis, tumour growth and bevacizumab resistance by Hamdollah Zadeh, Maryam A., Amin, Elianna M., Hoareau-Aveilla, Coralie, Domingo, Enric, Symonds, Kirsty E., Ye, Xi, Heesom, Katherine J., Salmon, Andrew, D'Silva, Olivia, Betteridge, Kai B., Williams, Ann C., Kerr, David J., Salmon, Andrew H.J., Oltean, Sebastian, Midgley, Rachel S., Ladomery, Michael R., Harper, Steven J., Varey, Alexander H.R., Bates, David O.

“…The angiogenic capability of colorectal carcinomas (CRC), and their susceptibility to anti-angiogenic therapy, is determined by expression of vascular…”
Get full text

Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia Nomogram by Lo, Serigne N, Ma, Jiawen, Scolyer, Richard A, Haydu, Lauren E, Stretch, Jonathan R, Saw, Robyn P M, Nieweg, Omgo E, Shannon, Kerwin F, Spillane, Andrew J, Ch'ng, Sydney, Mann, Graham J, Gershenwald, Jeffrey E, Thompson, John F, Varey, Alexander H R

“…For patients with primary cutaneous melanoma, the risk of sentinel node (SN) metastasis varies according to several clinicopathologic parameters. Patient…”
Get full text

Vitamin D Deficiency in Burn Patients by SCHUMANN, Adelaide D, PAXTON, Rebecca L, SOLANKI, Nicholas S, KURMIS, Rochelle J, MACKIE, Ian P, VAREY, Alexander H. R, GREENWOOD, John Edward

“…Vitamin D deficiency has been reported in pediatric burn patients; however, no formal studies have been conducted in adult burn populations. The available…”
Get full text

Has the advent of modern adjuvant systemic therapy for melanoma rendered sentinel node biopsy unnecessary? by Varey, Alexander H.R., Thompson, John F., Howle, Julie R., Lo, Serigne N., Ch’ng, Sydney, Carlino, Matteo S.

“…The prognostic value of sentinel node biopsy (SNB) is well established and SNB was therefore adopted as a requirement for pathological staging of…”
Get full text

External validation in an Australian population of the EORTC-DeCOG nomogram predicting recurrence, distant metastasis and overall mortality in melanoma patients with positive sentinel lymph nodes by Li, Andrew T., Law, Jenaleen, Ch’ng, Sydney, Scolyer, Richard A., Thompson, John F., Lo, Serigne N., Varey, Alexander H.R.

“…Calculating an accurate prognosis for melanoma patients who have a positive sentinel node (SN) biopsy is important both for them and for their treating doctors…”
Get full text

Long-Term survival across breslow thickness categories: Findings from a Population-Based study of 210,042 Australian melanoma patients by Lo, Serigne N, Williams, Gabrielle J, Cust, Anne E, Varey, Alexander H R, Md, Sydney Ch'ng, Scolyer, Richard A, Thompson, John F

“…The prognosis of a patient with a primary cutaneous melanoma is known to be related to the Breslow thickness of their tumor. This study sought to determine…”
Get full text

Knowledge of sentinel lymph node status improves accuracy when predicting melanoma mortality and selecting patients for adjuvant immunotherapy by Lo, Serigne N., Varey, Alexander H. R., El Sharouni, Mary‐Ann, Scolyer, Richard A., Thompson, John F.

Get full text

Online tools for predicting melanoma survival: Including sentinel node status as a variable improves prediction accuracy by Lo, Serigne N., Varey, Alexander H. R., El Sharouni, Mary‐Ann, Scolyer, Richard A., Thompson, John F.

Get full text

Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas by El Sharouni, Mary-Ann, Ahmed, Tasnia, Varey, Alexander H R, Elias, Sjoerd G, Witkamp, Arjen J, Sigurdsson, Vigfús, Suijkerbuijk, Karijn P M, van Diest, Paul J, Scolyer, Richard A, van Gils, Carla H, Thompson, John F, Blokx, Willeke A M, Lo, Serigne N

“…Although the prognosis of patients with thin primary cutaneous melanomas (T1, ≤ 1.0 mm) is generally excellent, some develop recurrence. We sought to develop…”
Get full text

Development and validation of a novel model to predict recurrence-free survival and melanoma-specific survival after sentinel lymph node biopsy in patients with melanoma: an international, retrospective, multicentre analysis by Stassen, Robert C, Maas, Carolien C H M, van der Veldt, Astrid A M, Lo, Serigne N, Saw, Robyn P M, Varey, Alexander H R, Scolyer, Richard A, Long, Georgina V, Thompson, John F, Rutkowski, Piotr, Keilholz, Ulrich, van Akkooi, Alexander C J, Verhoef, Cornelis, van Klaveren, David, Grünhagen, Dirk J

“…The introduction of adjuvant systemic treatment for patients with high-risk melanomas necessitates accurate staging of disease. However, inconsistencies in…”
Get full text

Clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta‐analysis by Varey, Alexander H. R., Williams, Gabrielle J., Lo, Serigne N., Taing, Cecilia Y., Maurichi, Andrea, Santinami, Mario, Scolyer, Richard A., Thompson, John F.

“…Little guidance is currently available for managing patients with melanocytic tumours of uncertain or low malignant potential (MelTUMPs, including…”
Get full text

Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator by Varey, Alexander H R, Li, Isabel, El Sharouni, Mary-Ann, Simon, Julie, Dedeilia, Aikaterini, Ch'ng, Sydney, Saw, Robyn P M, Spillane, Andrew J, Shannon, Kerwin F, Pennington, Thomas E, Rtshiladze, Michael, Stretch, Jonathan R, Nieweg, Omgo E, van Akkooi, Alexander, Sullivan, Ryan J, Boland, Genevieve M, Gershenwald, Jeffrey E, van Diest, Paul J, Scolyer, Richard A, Long, Georgina V, Thompson, John F, Lo, Serigne N

“…Improvements in recurrence-free survival (RFS) were demonstrated in two recent randomized trials for patients with sentinel node (SN)-negative stage IIB or IIC…”
Get full text